Clinical Cancer Research AACR Conference on Cancer Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ornstein, D. K.
Right arrow Articles by Petricoin, E. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ornstein, D. K.
Right arrow Articles by Petricoin, E. F., III
Clinical Cancer Research Vol. 6, 353-356, February 2000
© 2000 American Association for Cancer Research


Advances in Brief

Characterization of Intracellular Prostate-specific Antigen from Laser Capture Microdissected Benign and Malignant Prostatic Epithelium

David K. Ornstein1, Chad Englert, John W. Gillespie, Cloud P. Paweletz, W. Marston Linehan, Michael R. Emmert-Buck and Emanuel F. Petricoin, III

Urologic Oncology Branch [D. K. O., W. M. L.], Pathogenetics Unit, Laboratory of Pathology [D. K. O., C. E.], and Cancer Genome Anatomy Project, Office of the Director [J. W. G., M. R. E-B.], National Cancer Institute, NIH, Bethesda, Maryland 20892; Division of Cytokine Biology, Center for Biologics Evaluation Research, Food and Drug Administration, Bethesda, Maryland 20892 [C. P. P., E. F. P.]; and Department of Chemistry, Georgetown University, Washington, D.C. 20057 [C. P. P.]

The proportion of unbound serum prostate-specific antigen (PSA; percent-free PSA) is reported to be lower in men with prostate cancer compared to men with benign prostates (U. H. Stenman et al., Cancer Res., 51: 222–226, 1991; H. Lilja et al., Clin. Chem., 37: 1618–1625, 1991; D. L. Woodrum et al., J. Urol., 159: 5–12, 1998; W. J. Catalona et al., J. Am. Med. Assoc., 279: 1542–1547, 1998). The majority of immunoreactive PSA in serum is complexed to {alpha}-1-antichymotrypsin (ACT). Two major mechanistic questions have previously been unknown: (a) Does PSA in human prostate cancer cells in tissue exist in a free or bound form? and (b) Is PSA produced by malignant cells in the free form because it has lost the ability to form a complex with ACT? Laser capture microdissection (LCM) enables the acquisition of pure populations of defined cell types from tissue (M. R. Emmert-Buck et al., Science, 274: 998-1001, 1996; R. F. Bonner et al., Science, 278: 1481–1483, 1997). This technology provides a unique opportunity to study intracellular protein composition and structure from human cells. In this study, we used LCM to assess the bound versus free form of intracellular PSA in both benign and malignant epithelium procured from prostate tissue.

One-dimensional and two-dimensional PAGE were performed on cellular lysates from LCM-procured benign and malignant prostate epithelium from frozen tissue specimens. Western blotting analysis of one-dimensional PAGE gels revealed a strong band at Mr 30,000 (expected molecular weight of unbound PSA) in all cases demonstrating that the vast majority of intracellular tumor and normal PSA exists within cells in the "free" form. Binding studies showed that PSA recovered from LCM-procured cells retained the full ability to bind ACT, and two-dimensional PAGE Western analysis demonstrated that the PSA/ACT complex was stable under strong reducing conditions. We conclude that intracellular PSA exists in the "free" form and that binding to ACT occurs exclusively outside of the cell.




This article has been cited by other articles:


Home page
Ann OncolHome page
E. M. Posadas, F. Simpkins, L. A. Liotta, C. MacDonald, and E. C. Kohn
Proteomic analysis for the early detection and rational treatment of cancer--realistic hope?
Ann. Onc., January 1, 2005; 16(1): 16 - 22.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
C. Li, Y. Hong, Y.-X. Tan, H. Zhou, J.-H. Ai, S.-J. Li, L. Zhang, Q.-C. Xia, J.-R. Wu, H.-Y. Wang, et al.
Accurate Qualitative and Quantitative Proteomic Analysis of Clinical Hepatocellular Carcinoma Using Laser Capture Microdissection Coupled with Isotope-coded Affinity Tag and Two-dimensional Liquid Chromatography Mass Spectrometry
Mol. Cell. Proteomics, April 1, 2004; 3(4): 399 - 409.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
C. K. Lapham, T. Romantseva, E. Petricoin, L. R. King, J. Manischewitz, M. B. Zaitseva, and H. Golding
CXCR4 heterogeneity in primary cells: possible role of ubiquitination
J. Leukoc. Biol., December 1, 2002; 72(6): 1206 - 1214.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
R. A. Craven, N. Totty, P. Harnden, P. J. Selby, and R. E. Banks
Laser Capture Microdissection and Two-Dimensional Polyacrylamide Gel Electrophoresis : Evaluation of Tissue Preparation and Sample Limitations
Am. J. Pathol., March 1, 2002; 160(3): 815 - 822.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
P. R. Srinivas, S. Srivastava, S. Hanash, and G. L. Wright Jr
Proteomics in Early Detection of Cancer
Clin. Chem., October 1, 2001; 47(10): 1901 - 1911.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. Stephan, K. Jung, M. Lein, P. Sinha, D. Schnorr, and S. A. Loening
Molecular Forms of Prostate-specific Antigen and Human Kallikrein 2 as Promising Tools for Early Diagnosis of Prostate Cancer
Cancer Epidemiol. Biomarkers Prev., November 1, 2000; 9(11): 1133 - 1147.
[Abstract] [Full Text]


Home page
J. Clin. Pathol.Home page
F. Fend and M. Raffeld
Laser capture microdissection in pathology
J. Clin. Pathol., September 1, 2000; 53(9): 666 - 672.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.